Rheumatology in Perspective · Olga Goodman, MD · A RheumaView publication
Professional education · English · Classification explorer v1.1
Explore classification, not an individual diagnosis. Results describe the selected findings under the named criteria set. An unchecked item is not a confirmed negative finding. Clinical diagnosis requires assessment of the full presentation and alternatives.

One family, two ways to draw it

The SpA family can be explored by named condition or by predominant axial and peripheral manifestations. The traditional teaching map includes overlapping disease and age-of-onset groups; it is not a reproduction of the original 1974 classification. Switch views and select a node to explore the relationship and the relevant criteria.

Traditional teaching view: named conditions and juvenile-onset presentations within the SpA family; these groups can overlap.

Select a node for details. On narrow screens, scroll the map sideways. Keyboard: Tab to a visible node, then Enter or Space.

Family

Spondyloarthritis (SpA)

Umbrella term for a group of inflammatory rheumatic diseases that share axial (sacroiliac and spinal) involvement, asymmetric peripheral oligoarthritis, enthesitis, dactylitis, extra-musculoskeletal inflammation (acute anterior uveitis, psoriasis, inflammatory bowel disease), familial clustering and a variable HLA-B27 association. These are shared patterns, not requirements in every patient; rheumatoid-factor positivity does not by itself exclude SpA.

Family Clinical entity Axial (ASAS) Peripheral (ASAS)

What holds the family together

HLA-B27 associationSacroiliitis and spondylitisEnthesitisDactylitisAsymmetric, lower-limb oligoarthritisAcute anterior uveitisPsoriasisInflammatory bowel diseasePreceding genitourinary or enteric infectionOften RF-negative; not an exclusion ruleFamilial aggregationResponse to NSAIDs
Three kinds of criteria coexist. Whole-group sets (Amor 1990, ESSG 1991) capture "SpA of any type"; manifestation-based sets (ASAS axial 2009, ASAS peripheral 2011) split by predominant site; entity-specific sets (modified New York for AS, CASPAR for PsA, ILAR for juvenile disease) define one member. Explore the major criteria sets with live checkers, alongside historical and entity-specific summaries.

Axial spondyloarthritis

Disease centred on the sacroiliac joints and spine. Two criteria sets are in current use: the modified New York criteria (1984) define ankylosing spondylitis by radiographic sacroiliitis, and the ASAS criteria (2009) cover the whole axial spectrum, radiographic and non-radiographic.

ASAS classification criteria for axial SpA

Year 2009
Source Rudwaleit et al., Ann Rheum Dis
Sensitivity 82.9%
Specificity 84.4%
Imaging arm alone 66.2% / 97.3%
Radiographic or non-radiographic? Radiographic status is determined by sacroiliac radiographs, independently of which ASAS arm is met. Unperformed or inconclusive radiographs do not establish nr-axSpA. When axSpA is clinically established, definite radiographic sacroiliitis supports r-axSpA (also called ankylosing spondylitis); absence of that radiographic threshold supports nr-axSpA. Neither MRI positivity nor the clinical arm alone determines radiographic status.

Modified New York criteria for ankylosing spondylitis

Year 1984
Source van der Linden, Valkenburg, Cats, Arthritis Rheum
Defines definite and probable AS
What changed from 1966. The back-pain criterion acquired an inflammatory character (improves with exercise, not relieved by rest), spinal limitation was required in two planes rather than three, chest expansion was referenced to age- and sex-specific norms, and unilateral grade 3 or 4 sacroiliitis became sufficient for the radiological criterion.

Inflammatory back pain: three definitions

Calin 1977, ≥4 of 5
Berlin 2006, ≥2 of 4 (sensitivity 70.3%, specificity 81.2%)
ASAS expert 2009, ≥4 of 5 (sensitivity 77.0%, specificity 91.7%)

Chronic back pain is the ASAS axial entry symptom; it does not have to fulfil an inflammatory back-pain definition. Inflammatory back pain is one of the eleven additional SpA features. Tick the characteristics present and compare which definitions are satisfied.

Radiographic sacroiliitis grading (New York) and the ASAS MRI definition

Schematic, not a radiograph: iliac side on the left, sacral side on the right. Brighter bands = sclerosis, dark bites = erosions, bright block = bony bridging.

Grade 0: normal

Normal sacroiliac joints. Cortical margins are sharp and the joint space is uniform.

ASAS definition of a positive MRI (sacroiliitis)

  • 2009 (Rudwaleit et al.): active inflammatory lesions of the sacroiliac joints with definite bone-marrow oedema or osteitis (STIR, or T1 after gadolinium) in the typical subchondral or periarticular location, highly suggestive of SpA. Required: one lesion on at least two consecutive slices, or at least two lesions on a single slice. Synovitis, enthesitis or capsulitis alone is not sufficient; structural lesions alone (erosions, fat, sclerosis, ankylosis) were not sufficient.
  • 2016 update (Lambert et al.): clear subchondral bone-marrow oedema with an overall appearance highly suggestive of axSpA remains central. The earlier slice-count rule is not a stand-alone threshold. Structural lesions can support interpretation but do not, by themselves, satisfy the active-MRI definition.
  • 2019 lesion definitions (Maksymowych et al.): standardised descriptions of active and structural lesions, including erosion, fat metaplasia, backfill and ankylosis. This work did not replace the active-MRI requirement with structural lesions alone.
  • Clinical interpretation: load-related, postpartum and other mimics must be considered. A positive classification MRI is not an individual diagnosis. Later research on structural-lesion thresholds is discussed separately from the established definition.

Historical criteria for ankylosing spondylitis

Rome criteria, 1961

European Congress of Rheumatology, Rome; published by Kellgren, 1963

Clinical
  • Low back pain and stiffness for more than 3 months, not relieved by rest
  • Pain and stiffness in the thoracic region
  • Limited motion in the lumbar spine
  • Limited chest expansion
  • History or evidence of iritis or its sequelae
Radiological
  • Bilateral sacroiliac changes characteristic of ankylosing spondylitis (excluding bilateral osteoarthritis of the sacroiliac joints)
Definite AS
  • Bilateral sacroiliac changes characteristic of AS plus at least one clinical criterion, or
  • At least four clinical criteria

New York criteria, 1966

Bennett and Burch, from the New York symposium on population studies of the rheumatic diseases

Clinical
  • Limitation of motion of the lumbar spine in all three planes: anterior flexion, lateral flexion and extension
  • History or presence of pain at the dorsolumbar junction or in the lumbar spine
  • Limitation of chest expansion to 2.5 cm or less, measured at the level of the fourth intercostal space
Radiological
  • Sacroiliitis graded 0–4 (the grading still used today)
Definite AS
  • Grade 3–4 bilateral sacroiliitis plus at least one clinical criterion, or
  • Grade 3–4 unilateral or grade 2 bilateral sacroiliitis plus clinical criterion 1, or plus both criteria 2 and 3
Probable AS
  • Grade 3–4 bilateral sacroiliitis with no clinical criteria
The Rome scheme also allowed a clinical-only route; definite AS under the New York scheme required radiographic sacroiliitis. These historical schemes should not be used as contemporary diagnostic rules. The ASAS axial framework later incorporated MRI and a clinical arm.

Peripheral spondyloarthritis

Predominantly peripheral disease presents with arthritis, enthesitis or dactylitis. The 2011 validation framework studied peripheral presentations without current back pain; current inflammatory back pain leads to assessment of the axial framework and its entry requirements. Axial and peripheral disease can coexist; incidental mechanical back pain does not automatically establish an axial phenotype.

ASAS classification criteria for peripheral SpA

Year 2011
Source Rudwaleit et al., Ann Rheum Dis
Sensitivity 77.8%
Specificity 82.9%
Combined ASAS set (axial + peripheral) 79.5% / 83.3%
Reading the second route. Use one current peripheral manifestation for entry. The other peripheral domains may count from current findings or qualifying past history, plus past inflammatory back pain and family history. Do not count the entry domain twice. Two additional distinct features satisfy the second route. Most peripheral psoriatic, reactive, IBD-associated and undifferentiated SpA sits here.

Whole-group criteria

Before the ASAS split, two sets classified spondyloarthritis of any kind. Both still appear in epidemiology and in trials of undifferentiated disease, and the Amor score remains a useful teaching device for the weight of each feature.

European Spondylarthropathy Study Group (ESSG) criteria

Year 1991
Source Dougados et al., Arthritis Rheum
Sensitivity ≈87%
Specificity ≈87%
Note values with radiographic sacroiliitis included; 78% / 90% without

Amor criteria

Year 1990
Source Amor, Dougados, Mijiyawa, Rev Rhum Mal Osteoartic
Threshold ≥6 points
Sensitivity ≈90%
Specificity ≈87%

Entity-specific classifications

Each named member of the family has its own scheme: validated criteria for psoriatic arthritis and juvenile disease, and consensus or descriptive classifications for reactive and IBD-associated arthritis.

CASPAR criteria for psoriatic arthritis

Year 2006
Source Taylor et al., Arthritis Rheum
Threshold ≥3 points with inflammatory articular disease
Sensitivity 91.4%
Specificity 98.7%

Clinical patterns of PsA (Moll and Wright, 1973)

PatternDescription
Asymmetric oligoarthritisFewer than five joints, often with dactylitis; the commonest pattern in the original series
Symmetric polyarthritisRheumatoid-like distribution; rheumatoid-factor positivity does not exclude PsA. Frequency varies across cohorts
Distal interphalangeal predominantDIP joints of hands and feet, usually with adjacent nail disease
Arthritis mutilansOsteolysis with telescoping digits; rare
SpondylitisSacroiliitis and spondylitis, often asymmetric, with or without peripheral disease; today "axial PsA"
Patterns overlap and evolve over time, so they describe phenotype rather than classify patients. Under ASAS criteria, psoriasis counts as a feature in both the axial and peripheral sets; whether axial PsA should be classified separately from axSpA with psoriasis is an open question under study by ASAS and GRAPPA.

Reactive arthritis

Status no validated classification criteria
Working proposal 4th International Workshop on Reactive Arthritis, Berlin 1999 (Braun et al., J Rheumatol 2000)

Berlin workshop proposal

Major criteria
  • Arthritis with two of three: asymmetric, mono- or oligoarticular, predominantly lower limb
  • Preceding symptomatic infection: enteritis or urethritis 3 days to 6 weeks before arthritis
Minor criteria
  • Evidence of the triggering infection: positive urine or swab test for Chlamydia trachomatis, or positive stool culture for enteric pathogens
  • Evidence of persistent synovial infection: positive immunohistology or PCR for Chlamydia
Definite reactive arthritis: both major criteria plus a relevant minor criterion
Probable reactive arthritis: both major criteria without a minor criterion, or one major criterion with one or more minor criteria

Classification by trigger

GroupUsual organisms
Post-entericSalmonella, Shigella, Yersinia, Campylobacter; also Clostridioides difficile
Post-urogenital (sexually acquired)Chlamydia trachomatis; less certainly Ureaplasma and Mycoplasma species
OtherPost-streptococcal arthritis and arthritis after intravesical BCG are usually kept outside the SpA concept

The historical "Reiter's syndrome" triad (arthritis, urethritis, conjunctivitis) is now regarded as one presentation of reactive arthritis rather than a separate entity. Within ASAS criteria a preceding infection is a feature of peripheral SpA.

Arthritis associated with inflammatory bowel disease

Peripheral disease Orchard, Wordsworth, Jewell, Gut 1998
Axial disease axial SpA in the IBD context; separate from the original Orchard peripheral types
TypeJointsCourseRelation to gut activityAssociations
Type 1, pauciarticularFewer than five joints; typically asymmetric large-joint disease, often in the lower limbsAcute, self-limiting attacks, usually under ten weeksParallels bowel flaresUveitis, erythema nodosum; HLA-B27, B35, DRB1*0103
Type 2, polyarticularFive or more, small joints (MCP), symmetricPersistent for months to yearsIndependent of bowel activityUveitis; HLA-B44
Axial involvement (separate category)Sacroiliac joints and spine, with or without peripheral arthritisChronic, behaves like axial SpAIndependent of bowel activityHLA-B27 in a minority to about half, weaker than in AS
Imaging sacroiliitis may occur without typical back symptoms in IBD and requires clinical interpretation. The Orchard type 1/type 2 description concerns peripheral arthritis; “type 3” is not an original Orchard category. IBD remains an important clinical association even though the ASAS framework classifies axial and peripheral manifestations.

Juvenile spondyloarthritis

The ILAR JIA framework requires onset before age 16, arthritis lasting at least six weeks and exclusion of other causes. Juvenile SpA overlaps several paediatric categories; the summaries below are not stand-alone diagnostic checklists.
Onset before the 16th birthday
Current scheme ILAR classification of juvenile idiopathic arthritis, second revision, Edmonton 2001 (Petty et al., J Rheumatol 2004)
Proposed revision PRINTO provisional criteria, 2019

Enthesitis-related arthritis (ILAR)

Arthritis and enthesitis, or arthritis or enthesitis with at least two of:

  • Sacroiliac joint tenderness or inflammatory lumbosacral pain, present or by history
  • HLA-B27 positive
  • Onset of arthritis in a boy older than 6 years
  • Acute, symptomatic anterior uveitis
  • Ankylosing spondylitis, enthesitis-related arthritis, sacroiliitis with IBD, reactive arthritis or acute anterior uveitis in a first-degree relative
Exclusions: psoriasis in the patient or a first-degree relative; IgM rheumatoid factor on two occasions at least three months apart; systemic JIA.

Juvenile psoriatic arthritis (ILAR)

Arthritis and psoriasis, or arthritis with at least two of:

  • Dactylitis
  • Nail pitting or onycholysis
  • Psoriasis in a first-degree relative
Exclusions: arthritis in an HLA-B27-positive boy beginning after the 6th birthday; AS, ERA, sacroiliitis with IBD, reactive arthritis or acute anterior uveitis in the patient, or a history in a first-degree relative; IgM rheumatoid factor on two occasions at least three months apart; systemic JIA.
PRINTO proposal (Martini et al., 2019). A provisional revision under validation replaces the ILAR categories with, among others, "enthesitis/spondylitis-related JIA", which describes three routes: peripheral arthritis and enthesitis; arthritis or enthesitis with at least three months of inflammatory back pain and imaging sacroiliitis; or arthritis or enthesitis with at least two of SI-joint tenderness, inflammatory back pain, HLA-B27, acute symptomatic anterior uveitis and SpA in a first-degree relative. This provisional framework differs from ILAR; it is not a universal replacement for it. Juvenile SpA can also be classified with adult sets: the ASAS axial and peripheral criteria and the ESSG and Amor sets have all been applied to adolescent cohorts, with the caveat that peripheral, enthesitis-dominant onset is far more typical than early axial disease.

How the classification evolved

From radiographic ankylosing spondylitis to a manifestation-based spectrum. Open any entry for what it introduced.

    Notes and sources

    Classification is not diagnosis

    Classification criteria are written to assemble homogeneous cohorts for research: they trade sensitivity for specificity and assume the disease is already suspected. Applying them to an unselected patient, especially the clinical arm of the ASAS axial criteria in someone with a low pre-test probability, overestimates disease. Diagnosis weighs the same features by their likelihood ratios (the Berlin diagnostic algorithm of Rudwaleit et al., 2004, is one formal version), considers alternatives such as osteitis condensans ilii, diffuse idiopathic skeletal hyperostosis and mechanical back pain, and can be made when no criteria set is fulfilled.

    Nomenclature in use

    • SpA: spondyloarthritis, preferred over "spondylarthropathy" and "seronegative spondarthritides"
    • axSpA: axial SpA, comprising r-axSpA (radiographic, equivalent to ankylosing spondylitis) and nr-axSpA (non-radiographic)
    • pSpA: peripheral SpA
    • uSpA: undifferentiated SpA, a term largely absorbed by nr-axSpA and pSpA
    • ERA: enthesitis-related arthritis, the ILAR category for juvenile SpA

    Key sources

    1. Kellgren JH. Diagnostic criteria for population studies (Rome criteria). Bull Rheum Dis, 1962.
    2. Bennett PH, Burch TA. New York symposium on population studies of the rheumatic diseases: new diagnostic criteria. Bull Rheum Dis, 1967.
    3. Moll JMH, Wright V. Psoriatic arthritis. Semin Arthritis Rheum, 1973.
    4. Moll JMH, Haslock I, Macrae IF, Wright V. Associations between ankylosing spondylitis, psoriatic arthritis, Reiter's disease, the intestinal arthropathies, and Behçet's syndrome. Medicine (Baltimore), 1974.
    5. Calin A, Porta J, Fries JF, Schurman DJ. Clinical history as a screening test for ankylosing spondylitis. JAMA, 1977.
    6. van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria. Arthritis Rheum, 1984.
    7. Amor B, Dougados M, Mijiyawa M. Critères de classification des spondylarthropathies. Rev Rhum Mal Osteoartic, 1990.
    8. Dougados M, van der Linden S, Juhlin R, et al. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum, 1991.
    9. Orchard TR, Wordsworth BP, Jewell DP. Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history. Gut, 1998.
    10. Braun J, Kingsley G, van der Heijde D, Sieper J. On the difficulties of establishing a consensus on the definition of and diagnostic investigations for reactive arthritis: results of the 4th International Workshop, Berlin 1999. J Rheumatol, 2000.
    11. Petty RE, Southwood TR, Manners P, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton 2001. J Rheumatol, 2004.
    12. Rudwaleit M, Metter A, Listing J, Sieper J, Braun J. Inflammatory back pain in ankylosing spondylitis: a reassessment of the clinical history for application as classification and diagnostic criteria. Arthritis Rheum, 2006.
    13. Taylor W, Gladman D, Helliwell P, et al. Classification criteria for psoriatic arthritis: development of new criteria from a large international study (CASPAR). Arthritis Rheum, 2006.
    14. Rudwaleit M, van der Heijde D, Landewé R, et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis, 2009.
    15. Sieper J, van der Heijde D, Landewé R, et al. New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from ASAS. Ann Rheum Dis, 2009.
    16. Rudwaleit M, Jurik AG, Hermann KG, et al. Defining active sacroiliitis on MRI for classification of axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI group. Ann Rheum Dis, 2009.
    17. Rudwaleit M, van der Heijde D, Landewé R, et al. The Assessment of SpondyloArthritis international Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis, 2011.
    18. Maksymowych WP, Lambert RG, Østergaard M, et al. MRI lesions in the sacroiliac joints of patients with spondyloarthritis: an update of definitions and validation by the ASAS MRI working group. Ann Rheum Dis, 2019.
    19. Martini A, Ravelli A, Avcin T, et al. Toward new classification criteria for juvenile idiopathic arthritis: first steps, PRINTO international consensus. J Rheumatol, 2019.
    20. Rudwaleit M, van der Heijde D, Khan MA, Braun J, Sieper J. How to diagnose axial spondyloarthritis early. Ann Rheum Dis, 2004.

    Primary sources and further reading

    Performance estimates refer to the cited derivation or validation cohorts, not to an individual patient. Historical sets retain their original dates. The ASAS peripheral paper reports 82.9% specificity in its abstract, although its figure caption prints 82.2%; the abstract value is shown here.